Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing forkhead box F1

Cancer Research

Volumn 70, Issue 5, 2010, Pages 2020-2029

  Nilsson, Jeanette ^a   Helou, Khalil ^b   Kovács, Anikó ^c   Bendahl, Pär Ola ^d   Bjursell, Gunnar ^a   Fernö, Mårten ^d   Carlsson, Peter ^a   Kannius Janson, Marie ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2; NUCLEAR FACTOR I; PROLACTIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXF1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; CARCINOGENESIS; CELL ADHESION; CELL ISOLATION; CELL MOTILITY; CELL STRUCTURE; EPITHELIUM; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPH NODE METASTASIS; MESENCHYME; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL; TUMOR GROWTH;

ANIMALS; BREAST NEOPLASMS; CELL ADHESION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL CELLS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; JANUS KINASE 2; MESODERM; MICE; MICE, INBRED BALB C; MICE, NUDE; NFI TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC;

EID: 77950197610     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1677     Document Type: Article

References (41)

1. Horseman ND. Prolactin and mammary gland development. J Mammary Gland Biol Neoplasia 1999;4:79-88.
2. Iavnilovitch E, Cardiff RD, Groner B, Barash I. Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice. Int J Cancer 2004;112:607-619
3. Humphreys RC, Hennighausen L. Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis. Cell Growth Differ 1999;10:685-694
4. Vomachka AJ, Pratt SL, Lockefeer JA, Horseman ND. Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth. Oncogene 2000;19:1077-1084
5. Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, Tornell J. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest 1997;100:2744-2751
6. Sultan AS, Xie J, LeBaron MJ, Ealley EL, Nevalainen MT, Rui H. Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene 2005;24:746-760
7. Nouhi Z, Chughtai N, Hartley S, Cocolakis E, Lebrun JJ, Ali S. Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells. Cancer Res 2006;66:1824-1832
8. Sultan AS, Brim H, Sherif ZA. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelialmesenchymal transition. Cancer Sci 2008;99:272-279
9. Johansson EM, Kannius-Janson M, Gritli-Linde A, Bjursell G, Nilsson J. Nuclear factor 1-C2 is regulated by prolactin and shows a distinct expression pattern in the mouse mammary epithelial cells during development. Mol Endocrinol 2005;19:992-1003.
10. Apt D, Liu Y, Bernard HU. Cloning and functional analysis of spliced isoforms of human nuclear factor I-X: interference with transcriptional activation by NFI/CTF in a cell-type specific manner. Nucleic Acids Res 1994;22:3825-3833
11. Chaudhry AZ, Lyons GE, Gronostajski RM. Expression patterns of the four nuclear factor I genes during mouse embryogenesis indicate a potential role in development. Dev Dyn 1997;208:313-325
12. Liu Y, Bernard HU, Apt D. NFI-B3, a novel transcriptional repressor of the nuclear factor I family, is generated by alternative RNA processing. J Biol Chem 1997;272:10739-10745
13. Lamani E, Wu Y, Dong J, Litaker MS, Acevedo AC, MacDougall M. Tissue- and cell-specific alternative splicing of NFIC. Cells Tissues Organs 2009;189:105-110
14. Nilsson J, Bjursell G, Kannius-Janson M. Nuclear Jak2 and transcription factor NF1-2: a novel mechanism of prolactin signaling in mammary epithelial cells. Mol Cell Biol 2006;26:5663-5674
15. Johansson EM, Kannius-Janson M, Bjursell G, Nilsson J. The p53 tumor suppressor gene is regulated in vivo by nuclear factor 1-C2 in the mouse mammary gland during pregnancy. Oncogene 2003;22:6061-6070
16. Kannius-Janson M, Johansson EM, Bjursell G, Nilsson J. Nuclear factor 1-C2 contributes to the tissue-specific activation of a milk protein gene in the differentiating mammary gland. J Biol Chem 2002; 277:17589-17596
17. Hellqvist M, Mahlapuu M, Blixt A, Enerback S, Carlsson P. The human forkhead protein FREAC-2 contains two functionally redundant activation domains and interacts with TBP and TFIIB. J Biol Chem 1998;273:23335-23343
18. Johansson MC, Baldetorp B, Bendahl PO, Johansson R, Oredsson SM. An improved marhematical method to estimate DNA synthesis time of bromodeoxyuridine-labelled cells, using FCM-derived data. Cell Prolif 1994;475-488
19. Dihge L, Bendahl PO, Grabau D, et al. Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer. Breast Cancer Res Treat 2008;109:255-262
20. Gotzmann J, Mikula M, Eger A, et al. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res 2004;566:9-20.
21. Sevignani C, Calin GA, Cesari R, et al. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines. Cancer Res 2003;63:1183-1187
22. Mahlapuu M, Ormestad M, Enerback S, Carlsson P. The forkhead transcription factor Foxf1 is required for differentiation of extraembryonic and lateral platemesoderm.Development 2001;128:155-166
23. Astorga J, Carlsson P. Hedgehog induction of murine vasculogenesis is mediated by Foxf1 and Bmp4. Development 2007;134:3753-3761
24. Ormestad M, Astorga J, Landgren H, et al. Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production. Development 2006;133:833-843
25. Mahlapuu M, Enerback S, Carlsson P. Haploinsufficiency of the forkhead gene Foxf1, a target for sonic hedgehog signaling, causes lung and foregut malformations. Development 2001;128:2397-2406
26. Malin D, Kim IM, Boetticher E, et al. Forkhead box F1 is essential for migration of mesenchymal cells and directly induces integrin-β3 expression. Mol Cell Biol 2007;27:2486-2498
27. Batlle E, Sancho E, Franci C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000;2:84-89
28. Eger A, Aigner K, Sonderegger S, et al. ΔEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 2005;24:2375-2385
29. Vesuna F, van Diest P, Chen JH, Raman V. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun 2008;367:235-241
30. Wu W, Coss D, Lorenson MY, Kuo CB, Xu X, Walker AM. Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways. Biochemistry 2003;42:7561-7570
31. Nguyen NQ, Cornet A, Blacher S, et al. Inhibition of tumor growth and metastasis establishment by adenovirus-mediated gene transfer delivery of the antiangiogenic factor 16K hPRL. Mol Ther 2007;15:2094-2100
32. Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 1993;133:1292-1299
33. Nebl G, Mermod N, Cato AC. Post-transcriptional down-regulation of expression of transcription factor NF1 by Ha-ras oncogene. J Biol Chem 1994;269:7371-7378
34. Yang BS, Gilbert JD, Freytag SO. Overexpression of Myc suppresses CCAAT transcription factor/nuclear factor 1-dependent promoters in vivo. Mol Cell Biol 1993;13:3093-3102
35. Johansson FK, Brodd J, Eklof C, et al. Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging. Proc Natl Acad Sci U S A 2004;101:11334-11337
36. Gronostajski RM. Roles of the NFI/CTF gene family in transcription and development. Gene 2000;249:31-45.
37. Carver EA, Jiang R, Lan Y, Oram KF, Gridley T. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol Cell Biol 2001;21:8184-8188
38. Soo K, O'Rourke MP, Khoo PL, et al. Twist function is required for the morphogenesis of the cephalic neural tube and the differentiation of the cranial neural crest cells in the mouse embryo. Dev Biol 2002;247:251-270
39. Mani SA, Yang J, Brooks M, et al. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci U S A 2007;104:10069-10074
40. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007;7:415-428
41. Wu Y, Zhou BP. New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin (Shanghai) 2008;40:643-650